πŸ‡ΊπŸ‡Έ FDA
Patent

US 9295674

Metalloporphyrin neurological treatments

granted A61KA61K31/409A61K31/44

Quick answer

US patent 9295674 (Metalloporphyrin neurological treatments) held by The Regents of the University of Colorado, a Body Corporate expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/409, A61K31/44, A61K31/555, A61K45/06